Lifecore Biomedical, Inc. - Common Stock (NQ:LFCR)

6.450 -0.070 (-1.07%)

Delayed Quote Updated: 2:58 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lifecore Biomedical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Deadline to Lead in Securities Fraud Lawsuit against Lifecore Biomedical Inc. is September 27, 2024 - Contact Kaplan Fox & Kilsheimer LLP

August 07, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Deadline to Lead in Securities Fraud Lawsuit against Lifecore Biomedical Inc. is September 27, 2024 - Contact Kaplan Fox & Kilsheimer LLP

August 07, 2024

NEW YORK, NY - (NewMediaWire) - August 07, 2024 - Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors that purchased Lifecore Biomedical Inc....

Via TheNewswire.com

Topics Fraud Lawsuit

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, CrowdStrike, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm

August 07, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Shareholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Lifecore Biomedical, Inc. (LFCR)

August 07, 2024

From Robbins LLP

Via GlobeNewswire

LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

August 07, 2024

From Schall Law

Via GlobeNewswire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LFCR

August 06, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)

August 05, 2024

From Glancy Prongay & Murray LLP

Via Business Wire

LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline

August 05, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Seritage, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm

August 04, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

August 04, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LFCR

August 02, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)

August 02, 2024

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Lifecore Biomedical, Inc. (LFCR) Investors

August 01, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Lifecore Biomedical, Inc. (LFCR) Investors

July 31, 2024

From Glancy Prongay & Murray LLP

Via Business Wire

LIFECORE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Lifecore Biomedical, Inc. and Encourages Investors to Contact the Firm

July 31, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Lifecore Biomedical, Inc. (LFCR) Investors

July 31, 2024

From Law Offices of Howard G. Smith

Via Business Wire

LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) INVESTOR ALERT: Investors With Large Losses in Lifecore Biomedical Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

July 31, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

July 31, 2024

From Schall Law

Via GlobeNewswire

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Lifecore Biomedical, Inc. Investors

July 30, 2024

From Kirby McInerney LLP

Via Business Wire

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore

July 30, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

July 30, 2024

From The Schall Law Firm

Via Business Wire

LFCR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

July 30, 2024

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Rosen Law Firm Urges Lifecore Biomedical, Inc. (NASDAQ: LFCR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

July 30, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

Lifecore Biomedical Announces Cooperation Agreement with 22NW

July 01, 2024

Provides for the Addition of 22NW Nominees Jason Aryeh and Matthew Korenberg, as Well as Humberto Antunes and Paul Johnson, to the Board

From Lifecore Biomedical, Inc.

Via GlobeNewswire

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 22, 2024

From Lifecore Biomedical, Inc.

Via GlobeNewswire

Lifecore Biomedical Completes Incremental Liquidity Initiatives

May 16, 2024

Recent Initiatives Provide Approximately $8 Million of Non-Dilutive, Incremental Liquidity through Various Amendments with Lenders

From Lifecore Biomedical, Inc.

Via GlobeNewswire

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

May 14, 2024

WHY: NEW YORK, NY - (NewMediaWire) - May 14, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Lifecore...

Via TheNewswire.com

Topics Regulatory Compliance

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

May 14, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Regulatory Compliance

ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

May 10, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Regulatory Compliance

ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC

May 10, 2024

WHY: NEW YORK, NY - (NewMediaWire) - May 10, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Lifecore...

Via TheNewswire.com

Topics Regulatory Compliance

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.